Gaochao Guo

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth.

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth.

Journal: Frontiers in oncology

Published: March 05, 2026

Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms.

Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms.

Journal: Frontiers in neurology

Published: January 24, 2026

Temporal muscle thickness as a preoperative predictor of motor aphasia in Moyamoya disease.

Temporal muscle thickness as a preoperative predictor of motor aphasia in Moyamoya disease.

Journal: Frontiers in neurology

Published: March 23, 2025

Transmission electron microscopy ultrastructural characteristics of the distal middle cerebral artery in moyamoya disease.

Transmission electron microscopy ultrastructural characteristics of the distal middle cerebral artery in moyamoya disease.

Journal: Scientific reports

Published: January 19, 2025

Vascular architecture characters and risk factors analysis of unstable moyamoya disease.

Vascular architecture characters and risk factors analysis of unstable moyamoya disease.

Journal: Frontiers in neurology

Published: March 08, 2024

IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.

IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.

Journal: Cellular signalling

Published: August 08, 2023

IKBKE regulates angiogenesis by modulating VEGF expression and secretion in glioblastoma.

IKBKE regulates angiogenesis by modulating VEGF expression and secretion in glioblastoma.

Journal: Tissue & cell

Published: May 13, 2023

Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study.

Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study.

Journal: Frontiers in surgery

Published: November 06, 2022

Case Report: Curative effect of OA-PICA protected bypass in severe PICA-complicated vertebral artery stenosis treatment: Results in 3 cases.

Case Report: Curative effect of OA-PICA protected bypass in severe PICA-complicated vertebral artery stenosis treatment: Results in 3 cases.

Journal: Frontiers in surgery

Published: October 19, 2022

Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease.

Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease.

Journal: Computational intelligence and neuroscience

Published: May 24, 2022

Case Report: The Different Fates of Three Aneurysms: Diagnosis and Treatment Strategies for Unruptured Intracranial Aneurysms With Other Intracranial Diseases.

Case Report: The Different Fates of Three Aneurysms: Diagnosis and Treatment Strategies for Unruptured Intracranial Aneurysms With Other Intracranial Diseases.

Journal: Frontiers in surgery

Published: January 27, 2022

Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.

Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 12, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026